TURENNE ANDRE (President & CEO) sold 11.1% of their position (10.71K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $143.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/29/2020ACC: 0001104659-20-008187
DirectorOfficer· President & CEO
Since Jul 2018
-10.71K
Net shares
Net seller
$143.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.71K
Price / share
$13.36
Trade value
$143.02K
% of position
11.1%
1/21/2020
96.25K→85.55K
Total
Net shares
−10.71K
Net value
-$143.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2020 | S · Sale | −10.71K | $13.36 | $143.02K | 11.1% | 96.25K | 85.55K |
| Total | −10.71K | -$143.02K | ||||||
Derivative Transactions0
No derivative transactions reported